Abstract: Practical methodology is reported for the synthesis of a homologous series of side-chain-extended amino acids containing aminooxy functionality bearing orthogonal protection suitable for Fmoc peptide synthesis. These reagents may be useful for the preparation of libraries containing fragments joined by peptide linkers.
Fragment-based approaches to drug discovery have gained increasing importance in the pharmaceutical industry.
1 Tethered libraries represent a subclass of fragment-based methodologies. However, to date, tethered libraries have typically employed structurally simple linker elements, consisting mainly of polymethylene segments bearing terminal aminooxy groups that serve as anchoring points for fragment attachment. 2 However, increased library complexity, leading potentially to enhanced bioactivities, may be possible by combining the structural diversity of peptide scaffolds together with linker-based functionalized oxime ethers. Amino acids 1a-f and 2a were designed to serve as key components of linker-based peptide libraries by providing protected aminooxy groups appended onto the peptide backbone via methylene chains of increasing lengths (Figure 1 ). Final tethered products would be obtained by acid-catalyzed oxime ether deprotection and conjugation with fragment libraries. However, only the core structures of 1a, 3 1c 4 , and 1d 5 are known in the literature and efficient syntheses of the series 1a-f and 2a have not yet been reported. Practical methodology for the preparation of 1a-f and 2a bearing orthogonal protection designed for Fmoc-based peptide synthesis was the focus of the current study. Cross metathesis (CM) has found wide application for coupling through highly efficient carbon-carbon bond formation. 6 A CM approach for the synthesis of target compounds 1d-f required the N-Boc-protected aminooxy building blocks 4a-c, 7 which could be obtained by reaction of the corresponding bromides 3a-c with N-Boc-hydroxylamine and 1,8-diazabicyclo [5.4 .0]undec-7-ene (DBU) in CH 2 Cl 2 (Scheme 1). 8 The CM coupling of NFmoc-L-allylglycine O-benzyl ester (5) 6c with five equivalents of the respective substrates 4a-c in refluxing CH 2 Cl 2 using 5% Grubbs 2nd generation catalyst, [((PCy 3 )(Im(Mes) 2 )Ru=CHPh)] 9 provided the products 6a-c (Scheme 2), which were contaminated with small quantities of unwanted material resulting from homodimerization of reagent 4. It was advantageous to subject the crude mixtures directly to hydrogenation to provide the easily purified final products 1d-f. Based on combined yields over two steps, it was found that CM efficiency improved with increasing substrate chain length (1d, 40% yield; 1e, 53% yield and 1f, 72% yield). The shorter homologues 1a-c were prepared from Lserine (Ser), L-homoserine (HSer) and L-glutamic acid (Glu), respectively. Near quantitative conversion of Ser to N-Trt-L-serine O-methyl ester (N-Trt-Ser-OMe, 7 10 ) and reaction with N-hydroxyphthalimide under Mistunobu conditions, provided the globally-protected product 8 (79% yield, Scheme 3). Use of the N-Trt group was to minimize unwanted b-elimination during the Mitsunobu reaction. 11 Having served its purpose, the N-Trt group was while the side chain-elongated analogue 12 was obtained from commercially available N-Cbz-Glu-OBn (11) 13 by reduction of the free carboxylic acid group (Scheme 4). 14 When direct transformation of 10 to the phthalimidooxy product 15 under Mitsunobu conditions was accompanied by poor yields and the formation of cyclized by-products, the alcohols 10 and 12 were converted in quantitative yield to the corresponding mesyl esters 13 and 14.
15 Subsequent nucleophilic displacement using N-hydroxyphthalimide provided 15 and 16, respectively, in approximately 60-70% yields. To complete the synthesis of the target compounds, the phthalimidooxy intermediates 9, 15, and 16 were cleaved by treatment with methylhydrazine in CH 2 Cl 2 at 0°C, then protected as their N-Boc derivatives 17-19 by reaction with Boc anhydride (near quantitative yields for two steps, Scheme 5). Cleavage of the amino acid methyl esters of 17 and 18 (LiOH in aqueous THF) followed by Cbz hydrogenolysis and reprotection as the N-Fmoc derivatives provided the final products 1a and 1b in 58% and 81% yields over three steps. Hydrogenation of 19 and NFmoc reprotection gave 1c directly (47% yield). To determine whether the DBU/DMF conditions resulted in racemization at the a-amino center, 1c was evaluated for enantiomeric purity as follows. Phenylalanine dipeptides were prepared by solid-phase techniques (Figure 2) , and the resulting diastereomers were separated by reverse-phase HPLC ( Figure 3) . Analysis of the racemic D,L-phenylalanine containing dipeptides 20 indicated good separation of diastereomers. The dipeptide 22, prepared using enantiomerically pure L-phenylalanine, did not show detectable diastereomeric contamination, indicating that the ee value of 1c is >98%.
Use of the Boc-protected aminooxy-containing analogue 1a in solid-phase peptide synthesis is potentially limited by b-elimination during piperidine-mediated Fmoc deprotection. Indeed, attempted incorporation on NovaSyn ® TGR resin of 1a in place of threonine in the Tsg101-binding peptide, FITC-Ava-PEPTAPPEE-amide 16 gave only product resulting from b-elimination. 17 Therefore, the aminooxy Boc protecting group in 1a was replaced with the more electron-donating 4-methyltriphenylmethyl (Mtt) (final product 2a). This was achieved by deprotection of phthalamide 9 using methylhydrazine in CH 2 Cl 2 followed by reaction with MttCl (i-Pr 2 EtN, CH 2 Cl 2 ) to give the corresponding Mtt-protected aminooxy analogue 20 in quantitative yield (Scheme 6). Conversion to the N-Fmoc final product 2a was as described above for the preparation of target compounds 1a-c. Repeating the synthesis of the Tsg101-binding peptide described above using 2a rather than 1a gave the desired aminooxycontaining peptide as the major product with no b-elimination side product as detected by HPLC. In conclusion, the practical synthesis of a homologous series of aminooxy-containing amino acid analogues has been reported herein. These analogues are intended to serve as valuable building blocks for the post solid-phase construction of tethered oxime-based peptide libraries.
All experiments involving moisture-sensitive compounds were conducted under dry conditions (positive argon pressure) using standard syringe, cannula, and septa protocols. All anhydrous solvents were obtained commercially (Aldrich) and used directly. HPLCgrade hexanes, EtOAc, CH 2 Cl 2 , and MeOH were used in chromatography. Analytical TLC was performed using Analtech precoated plates (Uniplate, silica gel GHLF, 250 microns) containing a fluorescence indicator. NMR spectra were recorded using a Varian Inova 400 MHz spectrometer. Coupling constants are reported in hertz, and peak shifts are reported in d (ppm). Low-resolution mass spectra (ESI) were measured with using an Agilent 1200 LC/MSD-SL system, and high-resolution mass spectra (ESI or APCI) were measured by the University of California Riverside Mass Spectrometry Facility, Department of Chemistry, University of California, Riverside CA, 92521. Optical rotations were measured on a Jasco P-1010 polarimeter at 589 nm and IR spectra were obtained neat using a Jasco FT-IR/615 spectrometer.
Compounds 4a-c; General Procedure
To a mixture of alkenyl bromide 3a-c (10 mmol) and N-Boc-hydroxylamine (25 mmol) in CH 2 Cl 2 (1.0 mL) at 0 °C, was added DBU (7.5 mL) carefully. The mixture was warmed to r.t. and stirred overnight. The mixture was diluted with EtOAc (150 mL), washed with H 2 O (50 mL) and brine (50 mL), and purified by silica gel column chromatography (hexanes-EtOAc) to yield 4a-c as colorless oils.
N-(Prop-2-en-1-yloxy)carbamic Acid 1,1-Dimethylethyl Ester (4a) 7 Prepared from 3a; yield: 1.18 g (68%).
IR ( ESI-MS (+): m/z = 224.1 (M + Na) + .
Amino Acids 1d-f; General Procedure
A solution of alkene 4a-c (5.0 equiv) and the protected allylglycine 5 6c (1.0 equiv) in anhyd CH 2 Cl 2 (20 mL) was degassed under argon (5 min), then the Grubbs 2nd generation catalyst [(PCy 3 )(Im(Mes) 2 )Ru=CHPh] 9 (0.05 equiv) was added and the mixture was refluxed for 8 h. The solvent was evaporated by rotary evaporation and the residue was purified by silica gel column chromatography (hexanes-EtOAc) to yield crude 6a-c as colorless oils. Without further purification, a solution of 6 in EtOH (10 mL) was hydrogenated at r.t. under 1 atm H 2 over 10% Pd/C (1 h). The catalyst was removed by filtration and the filtrate was concentrated and purified by silica gel column chromatography (CH 2 Cl 2 -MeOH) to yield 1d-f as white waxes. (3S)-3-Carboxy-12,12-dimethyl-10-oxo-8,11-dioxa-2,9-diazadecanoic Acid 1-(9H-Fluoren-9-ylmethyl) Ester (1d) 
N-(Triphenylmethyl)-L-serine Methyl Ester (7) 10
To cooled MeOH (100 mL) at 0 °C was added acetyl chloride (10.0 mL) dropwise. The resulting solution was stirred for 15 min, then LSerine (5.0 g, 47.6 mmol) was added and the solution was stirred at reflux for 2 h and then cooled to r.t. The solvent was evaporated to provide H-Ser-OMe·HCl as a white solid (7.40 g, quant). To a suspension of this material (1.50 g, 9.74 mmol) in CH 2 Cl 2 (50 mL) at 0 °C was added Et 3 N (3.0 mL, 21.4 mmol) and trityl chloride (2.90 
O-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)-N-[(phenylmethoxy)carbonyl]-L-serine Methyl Ester (9)
To a solution of 8 (2.00 g, 3.95 mmol) in CH 2 Cl 2 (50 mL) at r.t. was added 37% HCl (0.50 mL) and the suspension was stirred for 1 h and then quenched by the addition of sat. NaHCO 3 (10 mL). The mixture was extracted with CH 2 Cl 2 (2 × 50 mL) and the combined organic layers were washed with brine (50 mL) and dried (Na 2 SO 4 ). The solvent was removed by rotary evaporation and the residue was dissolved in THF (30 mL) with H 2 O (10 mL). To this solution was added NaHCO 3 (498 mg, 5.92 mmol) and benzyl chloroformate (0.59 mL, 4.15 mmol) and the mixture was stirred overnight at r.t. THF was removed by rotary evaporation and the resulting aqueous phase was extracted with EtOAc (2 × 100 mL). The combined organic layer was washed with H 2 O (2 × 50 mL) and brine (50 mL), and dried (Na 2 SO 4 ). The residue obtained after evaporation of the solvent was purified by silica gel column chromatography (hexanes-EtOAc) to yield 9 as a viscous colorless oil ( (10) 12 or 5-hydroxy-N-[(phenylmethoxy)carbonyl]-L-norvaline (12; 14 1.0 equiv) in CH 2 Cl 2 (30 mL) at 0 °C was added Et 3 N (1.5 equiv) and MeSO 3 Cl (1.2 equiv) and the mixture was stirred for 1 h. The mixture was diluted with CH 2 Cl 2 (100 mL), the CH 2 Cl 2 layer was washed with H 2 O (50 mL) and brine (50 mL), dried (Na 2 SO 4 ), and the solvent evaporated. Purification of the residue obtained by silica gel column chromatography (hexanes-EtOAc) provided 13 (from 10) and 14 (from 12) as viscous colorless oils. 
Mesyl Esters 13 and 14; General Procedure To a solution of N-Cbz-L-homoserine O-methyl ester

N-Benzyloxycarbonyl-O-mesyl-L-serine
ESI-MS (+)
: m/z = 368.0 (M + Na) + .
5-[(Methylsulfonyl)oxy]-N-[(phenylmethoxy)carbonyl]-L-norvaline Phenylmethyl Ester (14)
Prepared from 12 (3.95 g, quant). This material was used in the next step without further purification. 1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl) 3324, 3066, 3033, 2965, 2936, 2361, 2336, 1725, 1698,  1539, 1276, 1186, 1127, 1018, 876, 736, 696 
5-[(
Protected Amino Esters 17-20; General Procedure
To a solution of intermediates 9, 15, or 16 (1.0 equiv) in CH 2 Cl 2 (20 mL) at 0°C was added methylhydrazine (1.5 equiv) and the mixture was stirred at 0°C (1 h). The mixture was passed through Celite and the filtrate was concentrated and dried under high vacuum (30 min). For product 20 see below. For products 17-19, the residue was redissolved in THF (50 mL) and to this was added Et 3 N (2.0 equiv) and Boc 2 O (2.0 equiv) and the solution was stirred overnight at r.t. The mixture was diluted with EtOAc (200 mL) and washed with H 2 O (2 × 50 mL) and brine (50 mL), and dried (Na 2 SO 4 ). Purification by silica gel column chromatography (hexanes-EtOAc) provided 17-19 as viscous colorless oils. For product 20, the residue mentioned above prepared by the treatment of 9 with methylhydrazine was dissolved in CH 2 Cl 2 (10 mL) and to this was added DIPEA (2.0 equiv) and 4-methyltrityl chloride (1.2 equiv) and the mixture was stirred for 1 h at r.t. The mixture was diluted with EtOAc (100 mL) and washed with H 2 O (50 mL) and brine (50 mL), and dried (Na 2 SO 4 ). Purification of the residue obtained by evaporation of the solvent by column chromatography (hexanes-EtOAc) using Et 3 Npretreated silica gel provided 20 as a white wax. {[(1,1-Dimethylethoxy)carbonyl]aminooxy}-N-[(phenylmethoxy) 
3-{[(1,1-Dimethylethoxy)carbonyl]aminooxy}-N-[(phenylmethoxy)carbonyl]-L-serine Methyl Ester (17)
5-
Amino Acids 1a-c and 2a; General Procedure
To a solution of intermediates 17, 18, or 20 (1.0 equiv) in THF (10 mL) containing H 2 O (10 mL) at 0 °C was added LiOH·H 2 O (1.2 equiv) and the mixture was stirred at 0°C (2 h). THF was removed by rotary evaporation and the residual aqueous phase was washed with Et 2 O (50 mL) and then acidified to pH 3-4 by the addition of aq 1 N HCl (Note: For 20 aq sat. NH 4 Cl was used rather than aq 1 N HCl.) The mixture was extracted with EtOAc (3 × 50 mL) and the combined EtOAc extracts were washed with H 2 O (50 mL) and brine (50 mL), and dried (Na 2 SO 4 ). The organic phase was concentrated and the residue was dissolved in MeOH (20 mL) and stirred with 10% Pd/C under 1 atm H 2 (2 h). (Note: The preparation of 1c began at this point by the direct hydrogenation of 19.) The Pd/C was removed by filtration and the filtrate was concentrated and the residue was dissolved in dioxane (10 mL) and H 2 O (10 mL). To this was added 9-fluorenylmethylsuccinimidyl carbonate (FmocOSu) (1.1 equiv) and NaHCO 3 (2.0 equiv) and the mixture was stirred overnight at r.t. The reaction solution was acidified to pH 3-4 by the addition of aq 1 N HCl (Note: For 2a aq sat. NH 4 Cl was used rather than aq 1 N HCl.) The mixture was extracted with EtOAc (3 × 50 mL) and the combined EtOAc extracts were washed with H 2 O (50 mL) and brine (50 mL), and dried (Na 2 SO 4 ). Purification by silica gel column chromatography (CH 2 Cl 2 -MeOH) provided final products 1a-c and 2a as viscous colorless oils. Lyophilization from MeCN-H 2 O provided white powders, which were suitable for solid-phase applications. (3S)-3-Carboxy-9,9-dimethyl-7-oxo-5,8-dioxa-2,6-diazadecanoic Acid 1-(9H-Fluoren-9-ylmethyl 
